Schulhoff & Co’s Bristol-Myers Squibb BMY Stock Holding History

Schulhoff & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Hold	20,914	–	–	0.52%	48
2025 Q4	$1.13M	Sell	20,914 -1,500	-7%	-$72.2K	0.48%	52
2025 Q3	$1.01M	Hold	22,414	–	–	0.43%	54
2025 Q2	$1.04M	Hold	22,414	–	–	0.46%	50
2025 Q1	$1.37M	Hold	22,414	–	–	0.61%	41
2024 Q4	$1.27M	Hold	22,414	–	–	0.46%	46
2024 Q3	$1.16M	Hold	22,414	–	–	0.48%	54
2024 Q2	$931K	Sell	22,414 -500	-2%	-$22.4K	0.42%	58
2024 Q1	$1.24M	Sell	22,914 -40	-0.2%	-$2.04K	0.54%	49
2023 Q4	$1.18M	Hold	22,954	–	–	0.56%	49
2023 Q3	$1.33M	Sell	22,954 -1,250	-5%	-$76.6K	0.67%	40
2023 Q2	$1.55M	Buy	24,204 +183	+0.8%	+$12.3K	0.72%	40
2023 Q1	$1.66M	Hold	24,021	–	–	0.77%	40
2022 Q4	$1.73M	Hold	24,021	–	–	0.8%	37
2022 Q3	$1.71M	Hold	24,021	–	–	0.89%	32
2022 Q2	$1.85M	Hold	24,021	–	–	0.86%	34
2022 Q1	$1.75M	Sell	24,021 -150	-0.6%	-$10.1K	0.74%	41
2021 Q4	$1.51M	Hold	24,171	–	–	0.62%	45
2021 Q3	$1.43M	Sell	24,171 -150	-0.6%	-$9.88K	0.64%	47
2021 Q2	$1.63M	Sell	24,321 -100	-0.4%	-$6.52K	0.72%	41
2021 Q1	$1.54M	Hold	24,421	–	–	0.7%	40
2020 Q4	$1.51M	Sell	24,421 -968	-4%	-$59.5K	0.76%	37
2020 Q3	$1.53M	Sell	25,389 -225	-0.9%	-$13.5K	0.82%	33
2020 Q2	$1.51M	Hold	25,614	–	–	0.89%	34
2020 Q1	$1.43M	Hold	25,614	–	–	0.89%	35
2019 Q4	$1.64M	Sell	25,614 -165	-0.6%	-$9.45K	0.77%	38
2019 Q3	$1.31M	Sell	25,779 -1,575	-6%	-$74K	0.64%	42
2019 Q2	$1.24M	Hold	27,354	–	–	0.64%	43
2019 Q1	$1.3M	Buy	27,354 +1,285	+5%	+$64K	0.7%	41
2018 Q4	$1.35M	Sell	26,069 -556	-2%	-$29.9K	0.85%	35
2018 Q3	$1.65M	Sell	26,625 -100	-0.4%	-$5.93K	0.92%	35
2018 Q2	$1.48M	Sell	26,725 -1,926	-7%	-$104K	0.88%	37
2018 Q1	$1.81M	Sell	28,651 -115	-0.4%	-$7.4K	1.06%	30
2017 Q4	$1.76M	Sell	28,766 -85	-0.3%	-$5.32K	0.99%	33
2017 Q3	$1.84M	Sell	28,851 -100	-0.3%	-$5.84K	1.09%	28
2017 Q2	$1.61M	Sell	28,951 -100	-0.3%	-$5.44K	0.99%	31
2017 Q1	$1.58M	Sell	29,051 -250	-0.9%	-$13.7K	0.97%	29
2016 Q4	$1.71M	Sell	29,301 -1,216	-4%	-$66.5K	1.05%	27
2016 Q3	$1.65M	Sell	30,517 -45	-0.1%	-$2.89K	1.01%	28
2016 Q2	$2.25M	Sell	30,562 -676	-2%	-$47.8K	1.39%	21
2016 Q1	$2M	Sell	31,238 -1,818	-5%	-$115K	1.31%	21
2015 Q4	$2.27M	Sell	33,056 -1,200	-4%	-$79.3K	1.54%	19
2015 Q3	$2.03M	Sell	34,256 -3,834	-10%	-$243K	1.45%	21
2015 Q2	$2.53M	Sell	38,090 -3,350	-8%	-$221K	1.62%	17
2015 Q1	$2.67M	Hold	41,440	–	–	1.66%	17
2014 Q4	$2.45M	Hold	41,440	–	–	1.47%	18
2014 Q3	$2.12M	Sell	41,440 -196	-0.5%	-$9.79K	1.32%	22
2014 Q2	$2.02M	Buy	41,636 +2,875	+7%	+$142K	1.25%	23
2014 Q1	$2.01M	Buy	38,761 +989	+3%	+$52.6K	1.36%	23
2013 Q4	$2.01M	Sell	37,772 -100	-0.3%	-$5.09K	1.37%	22
2013 Q3	$1.75M	Hold	37,872	–	–	1.27%	23
2013 Q2	$1.69M	Buy	+37,872	New	+$1.64M	1.28%	23

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Schulhoff & Co's BMY Position: Q1 2026 in Review

Schulhoff & Co held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 20,914 shares worth $1.27M. The position accounts for 0.52% of the portfolio, ranked #48.

Schulhoff & Co first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.67M in Q1 2015. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Schulhoff & Co held 20,914 shares of Bristol-Myers Squibb worth $1.27M as of Q1 2026.
Schulhoff & Co left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.52% of Schulhoff & Co's portfolio in Q1 2026, its #48 holding.
Schulhoff & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Schulhoff & Co's Bristol-Myers Squibb position peaked at $2.67M in Q1 2015.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Schulhoff & Co's 13F filing for Q1 2026, filed 11 May 2026.